Goldman Sachs has added Thermo Fisher Scientific to its Conviction Buy List, citing multiple growth drivers.The firm has a price target of $690 (~13% upside).
Thermo Fisher Scientific (TMO) announces that it has authorized the repurchase of $3B of shares.The authorization has no expiration date. The program replaces the company's...
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Basic Materials, Utilities and Technology sectors propelled shares lower. At the close in NYSE,...
"The global health industry was worth $8.45 trillion in 2018 and global healthcare could reach over $10 trillion by 2022," according to PolicyAdvice a US insurance specialist. And...
Healthcare, especially vaccine development and rollout efforts, has become one of the most widely-followed topics during the pandemic. And due to the pandemic, a large number of...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 42.53 | 42.83 | 42.42 | +0.06 | +0.14% | 766.70K | Toronto | |||
| 18.20 | 18.20 | 18.07 | +0.14 | +0.78% | 2.72K | Toronto | |||
| 23.07 | 23.45 | 23.05 | +0.13 | +0.57% | 2.63M | Toronto | |||
| 0.085 | 0.00 | 0.00 | 0.0000 | 0.00% | 4.60K | TSXV | |||
| 4.81 | 4.86 | 4.69 | +0.170 | +3.66% | 2.63M | Toronto | |||
| 6.28 | 6.47 | 6.24 | -0.06 | -0.95% | 4.05M | Toronto | |||
| 73.10 | 74.19 | 72.84 | -0.49 | -0.67% | 88.13K | Toronto | |||
| 0.98 | 1.06 | 0.00 | -0.11 | -10.09% | 1.13M | Toronto | |||
| 32.75 | 33.14 | 32.72 | -0.20 | -0.61% | 435.05K | Toronto | |||
| 15.11 | 15.42 | 13.57 | +2.060 | +15.79% | 866.10K | NEO | |||
| 27.96 | 28.11 | 27.91 | +0.06 | +0.22% | 1.48M | Toronto | |||
| 44.67 | 45.02 | 44.58 | -0.13 | -0.29% | 86.81K | Toronto | |||
| 167.63 | 168.00 | 166.16 | +1.07 | +0.64% | 206.03K | Toronto | |||
| 63.59 | 64.08 | 63.55 | -0.21 | -0.33% | 2.57M | Toronto | |||
| 47.67 | 48.09 | 47.33 | -0.18 | -0.38% | 1.11M | Toronto |
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. It offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines. Analytical Instruments segment provides a broad offering of instruments, consumables, software and services that are used for a range of applications in the laboratory. Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Services segment offers products and solutions needed for the laboratory.